Upsher-Smith Divests Three Women's Health Products to Vertical Pharmaceuticals

Mon, 03/24/2014 - 3:18pm

Upsher-Smith Laboratories, Inc., has entered into a definitive agreement under which New Jersey-based Vertical Pharmaceuticals, LLC has acquired Upsher-Smith's rights to Divigel (estradiol gel) 0.1%, Nexa Plus Rx Prenatal Vitamin, and Provella, a probiotic dietary supplement.  As part of the transaction, Upsher-Smith has transferred the New Drug Application (NDA) for Divigel to Vertical Pharmaceuticals. Additional terms related to the deal have not been disclosed. Mizuho Securities served as exclusive advisor to Upsher-Smith on this transaction.

"We are pleased to reach this agreement with Vertical Pharmaceuticals, a company that is strategically focused on Women's Health," said Mark Evenstad, President and Chief Executive Officer of Upsher-Smith. "We are excited to drive our base business forward and pursue our strategic objective of providing therapies that empower people living with CNS conditions to lead healthy, productive lives through our commercial and developmental efforts."



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.